Why the study?
Does Vitamin K1 prophylaxis prevent postcircumcision bleeding and abnormal prothrombin values in newborn infants?
Does Vitamin K1 prophylaxis prevent postcircumcision bleeding and abnormal prothrombin values in newborn infants?
Vitamin K1 prophylaxis effectively prevents postcircumcision bleeding and controls prothrombin time in newborns without causing increased bilirubinemia or hemolysis.
Answers are grounded in this paper and cite their sources.
Vitamin K1 prophylaxis was associated with reduced bleeding; supports hypothesis but requires randomized confirmation before practice change.
The prophylactic use of vitamin K in the newborn has been abandoned by some physicians because of conflicting reports as to its efficacy and safety. In the present study vitamin K 1 was given either in doses of 5 mg. by mouth daily to the mother in the last month of pregnancy or in doses of 5 mg. intramuscularly to the infant at birth. A test series of 133 infants was treated prophylactically in this way. The contratest series consisted of 50 untreated infants. Among the 50, postcircumcision bleeding occurred 4 times and abnormal prothrombin values were observed 14 times. In the test group there was no postcircumcision bleeding, and the postnatal increase in prothrombin time was controlled without evidence of increased bilirubinemia or hemolysis.
No takes yet. Share an insight, caveat, or question.
Teresa J. Vietti (1961) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: